Safety and Effectiveness of Bambini Kids Robot-Assisted Gait Training (RAGT) in Children With Cerebral Palsy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-10
SponsorCOSMO ROBOTICS CO., Ltd

About this trial

Cerebral palsy (CP) is a common cause of gait impairment in children, leading to limitations in mobility and daily activities. Although conventional physical therapy is widely used, it has limitations in delivering consistent and intensive training. Robot-assisted gait training (RAGT) has emerged as a promising approach to provide repetitive, high-intensity, and task-specific training, with potential benefits in gait function and motor performance.

The Bambini Kids exoskeleton is a pediatric robotic device designed to assist lower-limb movements, including hip, knee, and ankle joints, to facilitate more natural gait patterns.

This study aims to evaluate the safety and clinical performance of Bambini Kids in children with cerebral palsy and to generate clinical evidence to support its use in real-world rehabilitation settings.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient diagnosed with Cerebral Palsy

Age from 2 to 10 years old

Classified as Levels II to IV according to GMFCS

Manual Muscle Testing, MMT score of 0 to 4

Disqualifiers

Subjects who do not meet the criteria of age, height, weight, body dimensions, or joint range of motion

Subjects with skin lesions, pressure sores, infections, or other conditions at area where device touches and makes difficult to use device

Classified as Levels V according to GMFCS

Subjects with severe spasticity (MAS > 3), or those at risk of significant worsening of spasticity after training.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exoskeleton

    Device

    This device is a powered exoskeleton intended to be worn on lower limbs affected by paralysis or weakness. It is designed to directly actuate the user's lower limb joints via integrated motors to assist or enable gait. The subject will have intervention of robot-assisted gait training (RAGT) using Bambini Kids (Cosmo Robotics Co., Ltd) for three sessions per week, 30 minutes per session, for 4 weeks.

  • Rehabilitation physical therapy

    Other intervention

    The subject will have intervention of one-on-one gait rehabilitation therapy with physical therapist for the same duration as treatment group (three sessions per week, 30 minutes per session, for 4 weeks)

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Exoskeleton groupExperimental treatment 1 intervention
Group B: Conventional Therapy groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Gross Motor Function Measure 88 (GMFM-88)

The Gross Motor Function Measure (GMFM) is a standardized observational assessment tool used to evaluate changes in gross motor function over time in children with cerebral palsy, consisting of a total of 88 items. Functional performance is assessed across five domains: (A) lying and rolling, (B) sitting, (C) crawling and kneeling, (D) standing, and (E) walking, running, and jumping. The score for each domain is calculated and expressed as a percentage.

Time frame
Outcomes will be assessed at week 0, week 2, and week 4 for both treatment group and control group.

Secondary outcomes

1

10-Meter Walk Test (10MWT)

The time required for the subject to walk 10 meters will be measured to calculate gait speed. This test provides a simple and reliable method for objectively assessing gait ability and functional mobility.

Time frame
Outcomes will be assessed at week 0, week 2, and week 4 for both treatment group and control group.
2

Guardian Satisfaction Assessment

Acceptability, usability, and perceived effectiveness of robot-assisted gait training will be assessed from the caregiver's perspective using a 7-point Likert scale. The minimum value is 1 and the maximum value is 7 . 1-point means "Not helpful at all", and 7-point means "Very helpful". The mean score across all items will be used as the total score. Individual item results will be reported separately, and internal consistency will be evaluated.

Time frame
Outcomes will be assessed at week 4 for both treatment group and control group.

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Asan Medical centerRecruiting05505, Songpa, SeoulSouth Korea

Sponsors and contacts

Click on the lead sponsor to view all of their trials.